General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Roche(MODEST), Reata(MODEST), Fresenius(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT), Otsuka Pharmaceutical Co.(MODEST)
CONSULTING FEES/HONORARIA: Roche(MODEST), Reata(MODEST), Fresenius(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT), Otsuka Pharmaceutical Co.(MODEST)
© 2024 American College of Cardiology Foundation. All rights reserved.